Telos Capital Management Inc. Purchases 3,827 Shares of Danaher Co. (NYSE:DHR)

Telos Capital Management Inc. boosted its position in shares of Danaher Co. (NYSE:DHR) by 9.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 43,693 shares of the conglomerate’s stock after acquiring an additional 3,827 shares during the quarter. Danaher accounts for approximately 1.2% of Telos Capital Management Inc.’s investment portfolio, making the stock its 25th biggest holding. Telos Capital Management Inc.’s holdings in Danaher were worth $10,108,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in DHR. Fairfield Bush & CO. raised its position in Danaher by 10.9% during the first quarter. Fairfield Bush & CO. now owns 4,840 shares of the conglomerate’s stock worth $1,420,000 after acquiring an additional 475 shares in the last quarter. Zions Bancorporation N.A. increased its holdings in shares of Danaher by 19.3% in the first quarter. Zions Bancorporation N.A. now owns 2,468 shares of the conglomerate’s stock valued at $724,000 after purchasing an additional 400 shares during the last quarter. Covestor Ltd increased its holdings in shares of Danaher by 76.8% in the first quarter. Covestor Ltd now owns 495 shares of the conglomerate’s stock valued at $145,000 after purchasing an additional 215 shares during the last quarter. NewEdge Advisors LLC increased its holdings in shares of Danaher by 14.1% in the first quarter. NewEdge Advisors LLC now owns 31,530 shares of the conglomerate’s stock valued at $9,248,000 after purchasing an additional 3,897 shares during the last quarter. Finally, Bridgewater Associates LP increased its holdings in shares of Danaher by 135.9% in the first quarter. Bridgewater Associates LP now owns 35,270 shares of the conglomerate’s stock valued at $10,346,000 after purchasing an additional 20,320 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

DHR has been the topic of several research reports. JPMorgan Chase & Co. upped their price objective on shares of Danaher from $250.00 to $270.00 and gave the company an “overweight” rating in a report on Wednesday, December 20th. Citigroup upped their price objective on shares of Danaher from $255.00 to $280.00 and gave the company a “buy” rating in a report on Wednesday, January 31st. StockNews.com downgraded shares of Danaher from a “buy” rating to a “hold” rating in a report on Wednesday, January 31st. Royal Bank of Canada upped their price target on shares of Danaher from $254.00 to $282.00 and gave the company an “outperform” rating in a research note on Wednesday, January 31st. Finally, Raymond James upped their price target on shares of Danaher from $240.00 to $270.00 and gave the company an “outperform” rating in a research note on Wednesday, January 31st. Seven analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $267.43.

Insider Transactions at Danaher

In other news, SVP Daniel Raskas sold 23,757 shares of the stock in a transaction dated Monday, February 26th. The shares were sold at an average price of $252.00, for a total value of $5,986,764.00. Following the completion of the transaction, the senior vice president now owns 38,102 shares of the company’s stock, valued at $9,601,704. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, Director Walter G. Lohr sold 3,289 shares of the firm’s stock in a transaction that occurred on Thursday, February 15th. The shares were sold at an average price of $251.15, for a total value of $826,032.35. Following the completion of the transaction, the director now owns 14,129 shares in the company, valued at approximately $3,548,498.35. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, SVP Daniel Raskas sold 23,757 shares of the firm’s stock in a transaction that occurred on Monday, February 26th. The shares were sold at an average price of $252.00, for a total transaction of $5,986,764.00. Following the completion of the transaction, the senior vice president now owns 38,102 shares of the company’s stock, valued at approximately $9,601,704. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 32,957 shares of company stock valued at $8,265,802. 10.90% of the stock is currently owned by insiders.

Danaher Price Performance

Danaher stock traded down $1.25 during trading hours on Wednesday, reaching $239.09. 1,492,634 shares of the stock were exchanged, compared to its average volume of 2,685,781. The company has a market cap of $177.06 billion, a P/E ratio of 37.61, a price-to-earnings-growth ratio of 3.64 and a beta of 0.83. The company has a current ratio of 1.68, a quick ratio of 1.37 and a debt-to-equity ratio of 0.31. Danaher Co. has a twelve month low of $182.09 and a twelve month high of $259.00. The stock has a 50 day moving average of $249.42 and a two-hundred day moving average of $229.79.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, January 30th. The conglomerate reported $2.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.91 by $0.18. The firm had revenue of $6.41 billion for the quarter, compared to the consensus estimate of $6.10 billion. Danaher had a net margin of 17.26% and a return on equity of 12.25%. The business’s revenue for the quarter was down 10.2% on a year-over-year basis. During the same period in the prior year, the company posted $2.87 earnings per share. Equities analysts expect that Danaher Co. will post 7.62 EPS for the current fiscal year.

Danaher Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 26th. Stockholders of record on Thursday, March 28th will be issued a $0.27 dividend. The ex-dividend date is Wednesday, March 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.45%. This is a boost from Danaher’s previous quarterly dividend of $0.24. Danaher’s dividend payout ratio is 16.90%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.